AI assistant
MYECO GROUP LTD — Board/Management Information 2013
Oct 6, 2013
65304_rns_2013-10-06_81329a07-d5de-41b1-b86e-29233d81e1f7.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [588 x 74] intentionally omitted <==
==> picture [588 x 75] intentionally omitted <==
TO: COMPANY ANNOUNCEMENTS OFFICE ASX LIMITED
DATE: 7 October 2013
DIRECTOR APPOINTMENT
The Board of Cardia Bioplastics Limited (“Cardia” or the “Company”) is pleased to announce the appointment of Mr. Steven Bendel to the Cardia Board.
Mr.Bendel’s qualifications include a Bachelor of Education degree from Victoria College-Rusden with a Graduate Diploma of Business (Accounting) from Monash University. Mr.Bendel is also a member of CPA Australia.
Mr.Bendel currently is a sole proprietor of accountancy practice-Bendel Partners Pty Ltd. Through his accountancy practice, Mr.Bendel has experience dealing with a diverse range of clientele ranging from small and medium sized business (including a law firm, medical & dental service providers, financiers, importers and wholesalers, property developers), single and multi-tenanted commercial property investors & syndicates (suburban & regional shopping centres, bulky good clearance centres, child care facilities, national fast food outlets, factories, warehouses, residential and an aged accommodation facility) and is also actively involved in property syndications, property development, lease negotiations, sourcing and negotiating finance (short and long term) with major lending institutions.
The Directors welcome appointment of Mr.Bendel and look forward to his contribution to the Company as a NonExecutive Director.
Appendix 3X is attached for Mr.Bendel, outlining his Initial Interest in Cardia.
Pat Volpe Chairman
==> picture [593 x 62] intentionally omitted <==
Appendix 3X Initial Director’s Interest Notice
Rule 3.19A.1
Appendix 3X
Initial Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity - Cardia Bioplastics Limited
ABN- 89 064 755 237
We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Mr. Steven Bendel |
|---|---|
| Date of appointment | 7 October 2013 |
Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
20,000,000 -Fully Paid Ordinary Shares
- See chapter 19 for defined terms.
Appendix 3X Page 1
11/3/2002
Appendix 3X Initial Director’s Interest Notice
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Name of holder & nature of interest | Number & class of Securities |
|---|---|
| Note: Provide details of the circumstances giving | |
| rise to the relevant interest. | |
| Bendel Family Superannuation Fund | 20,000,000- Fully Paid Ordinary Shares |
| Direct-Beneficiary |
Part 3 – Director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | n/a |
|---|---|
| Nature of interest | n/a |
| Name of registered holder | n/a |
| (if issued securities) | |
| No. and class of securities to which | n/a |
| interest relates |
- See chapter 19 for defined terms.
Appendix 3X Page 2
11/3/2002